Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication
Artículo científico (JournalArticle)
From premorbid adjustment dimensions to clinical outcomes: exploring environmental stress and epigenetic influences on first-episode schizophrenia phenotypes
Introduction Schizophrenia is a complex and multifaceted mental disorder characterized by cognitive, emotional, and behavioral dysfunctions that significantly impact the patients' daily lives. Premorbid adjustment (PA) is a multidimensional framework, the severity of which has been associated with more severe phenotypic traits and unfavorable outcomes, offering insights into the development of this disorder. This study aims to characterize a group of first-episode schizophrenia (FES) patients based on academic (PAA) and social (PSA) PA, explore the overlap across these dimensions, and examine their associations with early clinical, environmental, and epigenetic factors, through methylation profile scores (MPS). Material and methods A total of 218 FES subjects were included. K-means clustering identified "poor" and "good" groups for PAA and PSA. Clusters overlaps were explored using multiple correspondence analysis and were characterized by sociodemographic, clinical, functional, and cognitive features. Associations with clinical, environmental factors and MPS were examined using multivariable models adjusted for key covariates. Results Poor-PAA individuals showed worse cognitive performance (working memory, attention, and executive function), lower educational level, and higher cannabis use. Poor-PSA individuals had more severe negative symptoms. MPS for early-life adversity and cannabis use were associated with PSA clusters, while MPS for birth weight and tobacco use were linked to PAA clusters. Conclusions PAA and PSA dimensions show distinct clinical, cognitive, functional, and epigenetic profiles. These findings support the use of premorbid functioning subtypes for identifying early markers and tailoring interventions., This study is part of a coordinated multicenter project funded by the Ministerio de Economía y Competitividad (PI08/0208, PI11/00325, PI14/00612) (M.B.); the Instituto de Salud Carlos III and the European Regional Development Fund (ERDF), A way to build Europe; the Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM); the CERCA Programme/Generalitat de Catalunya; and the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement (2021 SGR 01120).
Furthermore, this study is part of the projects PI24/00196 (C.G.-R. and G.M.) funded by Instituto de Salud Carlos II (ISCIII) and co-financed by the European Union, Centro de Investigación Biomédica en Red de salud Mental, CIBERSAM, ERCA Program/Generalitat de Catalunya and Secretaria d'Universitats i Recerca del Departament d'Economia I Coneixement (2017SGR1355). G.M. is a Serra Hunter Fellow, within the Tenure-elegible Lecturer Serra Hunter program (UB-LE-212-024, Generalitat de Catalunya). Supported by the Madrid Regional Government (R&D activities in Biomedicine S2022/BMD-7216 (AGES 3-CM), and CIBERSAM-ISCIII.